Get started
Trading Idea - Norma GroupThere are 2 possible scenarios. LONG goes to 51.00 EUR, SHORT goes down to 35.00 EUR! I am more bullish here! So LONG we go! ENTRY: 45.22 EUR TARGET: 51.00 EUR (+13% profit) STOP: 42.30 EUR Norma Group SE is a German manufacturer of technical connection technology. The company focuses on three product categories: clamps, connectors and fluidics. 1.) From a market point of view of the 1 hour time units, the share is above the support at EUR 39.20, which could mean rising prices. 2.) Connection technology specialist Norma benefits from market recovery 3.) According to initial estimates, the first quarter was excellent at Norma.
XETR:NOEJLong
by Traderherz-Analytics
Soccer BVB on watchlistSoccer should be profitable in the next year 2022 after Covid-19 pandemic will be not longer relevant. BVB is a successful soccer club in Germany, which may have a price rise after pandemic end. Currently we see the first breakout of the sideward channel and pullpack, which I would see as a "bull trap". So after drawdown is over (watch MACD) and entry for a rise is possible. Target price would be old highs of 2019, when the world was without corona, which is a long run and can make a great profit for the investor. On watchlist!
XETR:BVBLong
by smoki99
BioNTech could break the wide range upwardNeutral Outlook: Trading in a wide range Indicators: Neutral to Bullish Trend: overall bullish Stop-Loss: 140 EUR Target: 220 - 240 EUR BioNTech will get the approval or denial for it's vaccine (for the use for children at 12 or older) from the EMA today. This could boost the stock above the resistance at 169 EUR which would break the first range it's trading in. The second, much larger range is between the ATH (185 EUR) and 121 EUR. It's defined by an inside bar on the daily view. Considering the approval, the overall market and news flow for vaccines and the cheap valuation of BioNTech I would risk a shot here. Stop-Loss should be below the first range line at 140 EUR. Target is the area between the 38,2 and 61,8 Fib (220 - 240 EUR). Let's see what happens.
SWB:22UALong
by LGNDRY-Capital
Biontech with a target of 225€ for JuneBiontech had a run of 135% from April to May but also tanked up to -35% in a short period of time due to the Biden patent waive statement. Nevertheless, the FUD is over, we are still in a bullish momentum and the fundamentals are looking better than ever. Bear in mind, I'm drawing only charts here, eventhough my bullish forecast is also backed by the earning reports of Pfizer and Biontech itself. I won't post any numbers or calculations. Everyone has to do its own due dilligence. All I can say is, that the stock is undervalued at this prices currently. My long term targets are also higher than 225€. But for now I go with 225€ for early June. I also think that the price will leap up from quarter reports to quarter reports. To the chart: After the big -35% drop we had a real strong buy back, which is showing still a bullish momentum. Currently, we are forming a bullish pennant. If we measure the height of it and project it of a break out, we'll get a target nearby. 225€. The yellow, orange and red wave are messured wave extentions which are all targeting the same price range nearby 225€. We have not many resistances ahead of us currently. There is the last ATH of 185€ and at the same price range, the median line of the parallel channel. Breaking above it, would head us direclty to the upper boundary of the parallel channel at 225€. Risk: Forecasting a price target to a specific date is higly speculative and there is a high likelihood that I will be wrong. The stock price is highly manipulated due to the overall sentiment and external news. Eventhough the fundamentals are bullish, we could have a longer period of sidewards movement. That would change the outcome of the predicted target. Do your own due dilligence!
FWB:22UALong
by MuffyPuffy
3